Results 141 to 150 of about 4,329 (161)
Some of the next articles are maybe not open access.

Targeting FPR1 to prevent doxorubicin-induced cardiomyopathy

European Heart Journal Supplements
Abstract Background/Introduction Doxorubicin (DOX) is effective against cancer but can cause cardiotoxicity and immunosuppression, reducing its utility. Formyl peptide receptor-1 (FPR1) is essential for DOX-induced immunologic activation; however, a prevalent FPR1 variant (rs867228) diminishes this ...
L Schirone   +6 more
openaire   +1 more source

FPR1 Antagonist (BOC-MLF) Inhibits Amniotic Epithelial-mesenchymal Transition

Current Medical Science
Premature rupture of membranes (PROM) is a common pregnancy disorder that is closely associated with structural weakening of fetal membranes. Studies have found that formyl peptide receptor 1 (FPR1) activates inflammatory pathways and amniotic epithelialmesenchymal transition (EMT), stimulates collagen degradation, and leads to membrane weakening and ...
Xiao-Mei, Huang   +4 more
openaire   +2 more sources

Development of potent isoflavone-based formyl peptide receptor 1 (FPR1) antagonists and their effects in gastric cancer cell models

European Journal of Medicinal Chemistry, 2023
Mark Quinn   +2 more
exaly  

FPR1

AfCS-Nature Molecule Pages, 2006
openaire   +1 more source

Molecular Structure, Expression and Role of TAFA4 and its Receptor FPR1 in the Spinal Cord

Frontiers in Cell and Developmental Biology, 2022
Si-Pin Zhu   +2 more
exaly  

MODULATORS OF FPR1 AND METHODS OF USING THE SAME

2022
SHI FU-DONG   +6 more
openaire   +5 more sources

Evaluation of human leukocyte N-formylpeptide receptor (FPR1) SNPs in aggressive periodontitis patients

Genes and Immunity, 2003
Debora Pallos   +2 more
exaly  

Synthesis and evaluation of FPR1 inhibitors as a novel treatment for cancers [1331]

2021
Aghamohammadi, Amin   +6 more
openaire   +1 more source

Home - About - Disclaimer - Privacy